The Mesothelioma Center's September Support Group Session - Coping with "Chemo Brain"
•Download as PPTX, PDF•
1 like•5,062 views
During and after chemotherapy treatment, some mesothelioma patients experience forgetfulness, problems with "word finding" and difficulty concentrating. These are symptoms of a phenomenon called Chemo Brain. Generally considered a temporary condition that resolves considerably in the months after completing treatment, patients find it frustrating and stressful nonetheless. This presentation will discuss chemo brain and strategies to manage its symptoms.
Report
Share
Report
Share
Recommended
Cancer Survivor\'s Guide to Chemo Brain and Recovery
As a cancer survivor who has largely recovered from chemo brain, I reach out to conferences and support groups to speak on this important issue.
MG-GBS OT 537
Myasthenia gravis is a chronic autoimmune disorder affecting the neuromuscular junction, where acetylcholine receptor antibodies destroy acetylcholine receptors and impair neurotransmitter transmission, causing severe muscle weakness and fatigue. Signs and symptoms include easy fatigability and decreased reflexes. Diagnosis involves physical exam, blood tests for acetylcholine receptor antibodies, response to medications, and other tests. Treatment includes acetylcholinesterase inhibitors, steroids, thymectomy, IVIG, and plasmapheresis. Occupational therapy focuses on remedial exercises, compensatory strategies, and education to address challenges with activities of daily living.
Age Edits - Leslie Condon
The document discusses Beer's Criteria, which highlights potentially inappropriate medications for older adults that can cause adverse drug events. It identifies 3 categories of medications to avoid in the elderly based on a consensus of experts, including those that are potentially inappropriate or could worsen certain diseases. Common drugs on age edits lists include antihistamines, benzodiazepines, megestrol, and estrogens due to risks of confusion, falls, cognitive impairment, and other issues. The criteria are designed to promote safety for vulnerable older adults and are based on scientific evidence and expert consensus.
Supercharge your brain and ditch anxiety and depression for good!
Dr. Vivian DeNise of Patients Medical and Dr. Sandlin Lowe of The Amen Clinic New York explain the causes of anxiety and depression, the cutting-edge technology that can be used to diagnose deficiencies in the brain that cause these conditions and several non-invasive holistic medical approaches that we use to treat.
Medical research slideshare_march 12_2015
In the first study, researchers found that women who experienced early onset and frequent hot flashes had higher risks of cardiovascular disease. Specifically, these women showed poorer vascular health on certain indices compared to women with fewer or later hot flashes. A second study replicated these findings, further refining the understanding of how menopausal hot flashes may increase cardiovascular risks for some women. The studies suggest that experiencing hot flashes earlier and more frequently in midlife is linked to poorer vascular health and increased cardiovascular disease risk.
MedicalResearch.com: Medical Research Exclusive Interviews February 17 2015
MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.
MedicalResearch.com: Medical Research Exclusive Interviews July 2 2015
MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.
Rof in pp narrationfor dvdconversiononinternet_2
The chiropractor provides a positive long-term prognosis for the patient's condition if they receive chiropractic manipulative therapy. The summary outlines a 3-phase treatment plan involving chiropractic adjustments, exercises, and nutritional recommendations over 6 weeks with periodic progress exams. If left untreated, the structural problem could decay over time resulting in increased pain and need for symptom management rather than addressing the underlying issue.
Recommended
Cancer Survivor\'s Guide to Chemo Brain and Recovery
As a cancer survivor who has largely recovered from chemo brain, I reach out to conferences and support groups to speak on this important issue.
MG-GBS OT 537
Myasthenia gravis is a chronic autoimmune disorder affecting the neuromuscular junction, where acetylcholine receptor antibodies destroy acetylcholine receptors and impair neurotransmitter transmission, causing severe muscle weakness and fatigue. Signs and symptoms include easy fatigability and decreased reflexes. Diagnosis involves physical exam, blood tests for acetylcholine receptor antibodies, response to medications, and other tests. Treatment includes acetylcholinesterase inhibitors, steroids, thymectomy, IVIG, and plasmapheresis. Occupational therapy focuses on remedial exercises, compensatory strategies, and education to address challenges with activities of daily living.
Age Edits - Leslie Condon
The document discusses Beer's Criteria, which highlights potentially inappropriate medications for older adults that can cause adverse drug events. It identifies 3 categories of medications to avoid in the elderly based on a consensus of experts, including those that are potentially inappropriate or could worsen certain diseases. Common drugs on age edits lists include antihistamines, benzodiazepines, megestrol, and estrogens due to risks of confusion, falls, cognitive impairment, and other issues. The criteria are designed to promote safety for vulnerable older adults and are based on scientific evidence and expert consensus.
Supercharge your brain and ditch anxiety and depression for good!
Dr. Vivian DeNise of Patients Medical and Dr. Sandlin Lowe of The Amen Clinic New York explain the causes of anxiety and depression, the cutting-edge technology that can be used to diagnose deficiencies in the brain that cause these conditions and several non-invasive holistic medical approaches that we use to treat.
Medical research slideshare_march 12_2015
In the first study, researchers found that women who experienced early onset and frequent hot flashes had higher risks of cardiovascular disease. Specifically, these women showed poorer vascular health on certain indices compared to women with fewer or later hot flashes. A second study replicated these findings, further refining the understanding of how menopausal hot flashes may increase cardiovascular risks for some women. The studies suggest that experiencing hot flashes earlier and more frequently in midlife is linked to poorer vascular health and increased cardiovascular disease risk.
MedicalResearch.com: Medical Research Exclusive Interviews February 17 2015
MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.
MedicalResearch.com: Medical Research Exclusive Interviews July 2 2015
MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.
Rof in pp narrationfor dvdconversiononinternet_2
The chiropractor provides a positive long-term prognosis for the patient's condition if they receive chiropractic manipulative therapy. The summary outlines a 3-phase treatment plan involving chiropractic adjustments, exercises, and nutritional recommendations over 6 weeks with periodic progress exams. If left untreated, the structural problem could decay over time resulting in increased pain and need for symptom management rather than addressing the underlying issue.
DMT discussion group - Samantha Colhoun
1) Samantha Colhoun leads discussion groups for MS patients in Birmingham to educate them about disease-modifying therapies (DMTs) due to large waiting lists and clinic capacity issues.
2) The groups have separate sessions for first-line DMTs, Lemtrada, and Fingolimod. Patients are provided information and can handle demonstration devices.
3) During the groups, patients learn about various DMT options including how they work, side effects, monitoring needs, and adherence requirements through a presentation and discussion with a nurse.
Biomarkers in psychiatry
This document discusses the potential for using genetic biomarkers to improve treatment for psychiatric disorders. It notes that while the causes of psychiatric disorders are still unclear, identifying genetic markers that predict treatment response could help tailor medication selection. The document outlines several studies that have identified candidate genes associated with response to antidepressants and other psychotropic drugs. It acknowledges limitations but argues that further research in pharmacogenetics, using larger, more standardized studies, could help incorporate genetic testing into clinical practice to select safer, more effective treatments for individual patients.
Chronic Pain: Dangers and Opportunities
Dr. Barbara Turner's presentation from TPR's Think Health Science: Pain Management presentation, 6/9/16 at UT Health Science Center.
Dementia notes feb 2012
This document summarizes a presentation on the effectiveness and use of cholinesterase inhibitors in dementia. It discusses the three main cholinesterase inhibitors available in Canada - donepezil, rivastigmine, and galantamine - and provides details on their mechanisms of action, dosing, efficacy evidence, and guidelines for use. It also covers topics like optimizing therapy through adherence and expectations counseling, switching or discontinuing treatment, and situations where cholinesterase inhibitors should not be used, such as in mild cognitive impairment. The overall message is that cholinesterase inhibitors provide modest cognitive and functional benefits for mild to moderate Alzheimer's disease but each patient may respond differently based on tolerability and other factors.
Pain and Addiction: Minding the Medicine Cabinet
Slide show from Texas Public Radio and UTHSCSA's Think Health Science: Pain Management program on June 9, 2016.
Ketamine in Treatment Resistant Depression
1. Dr. Elisa Brietzke gave a presentation on intravenous ketamine as an evidence-based approach for treating depression. She discussed ketamine's mechanisms of action, pharmacokinetics, effectiveness for treating unipolar and bipolar depression based on meta-analyses and clinical studies, common side effects and their management, protocols for administration, and comparisons to esketamine.
2. Ketamine has rapid antidepressant effects within 24 hours when administered intravenously, but its effects only last 3-7 days without maintenance treatment. Repeated infusions over several weeks can provide more sustained benefits. Ketamine is generally well-tolerated but can increase blood pressure and heart rate.
3. While ket
Busting The Myths-Relapse Isn’t Treatment Failure
The National Institute on Drug Abuse (NIDA) describes addiction as a chronic, relapsing brain disease characterized by compulsive drug-seeking behavior despite knowing its harmful consequences. Since the chemicals of the drugs change the chemistry of the brain, addiction is commonly considered a “brain disease.” Due to such long-lasting changes, the problem of witnessing a relapse persists even after recovery.
Sequencing of Disease Modifying Treatments in Multiple Sclerosis - Belinda We...
1) There are two broad categories of disease modifying treatments (DMTs) for multiple sclerosis - drugs of moderate efficacy including beta interferons, glatiramer acetate, teriflunomide, and dimethyl fumarate, and drugs of high efficacy including alemtuzumab and natalizumab.
2) The prevailing practice is treatment escalation, starting with a first-line drug and changing treatments based on tolerability, safety, and efficacy. No relapses, disability progression, or MRI activity (NEDA) indicates treatment success.
3) There is no accepted treatment algorithm in the UK. Involving patients in decision making is important as the treatment landscape becomes more complex
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for cancer homeopat...
Homeopathic Doctor Anita Salunke practices in Chembur, Mumbai, India in her homeopathic clinic Mindheal. Find more information about homeopathic treatment at Mindheal. Welcome to safe, sure and effective homeopathic treatment cancer
Pregnancy & Addiction 2011 - Revision 2
This document provides an overview of addiction and pregnancy, including:
- Rates of drug and alcohol use during pregnancy range from 12-24% and pose risks to fetal development.
- Treatment includes medication-assisted therapy with methadone or buprenorphine, which can improve outcomes compared to untreated addiction.
- Babies exposed to opioids in utero may develop neonatal abstinence syndrome requiring supportive care and sometimes pharmacological treatment.
TBI and Holistic Neuropsychology
The document summarizes a presentation on traumatic brain injury (TBI) assessment and rehabilitation. It defines TBI and outlines the continuum of care, including initial assessment, treatment of primary and secondary injuries, and comprehensive rehabilitation involving multiple disciplines. It emphasizes a holistic neuropsychological approach that empowers patients, conveys understanding of deficits and recovery, and helps patients find meaning through collaborative assessment and goal-setting.
MedicalResearch.com: Medical Research Exclusive Interviews April 28 2015
MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.
Cognitive Behavorial Therapy for Insomnia k. Jensen f. Remillard
This document summarizes cognitive behavioral therapy for insomnia (CBT-I). It defines insomnia and discusses predisposing, precipitating, and perpetuating factors. It describes CBT-I as the first-line treatment for insomnia, focusing on addressing dysfunctional thoughts and behaviors. Key components of CBT-I include sleep hygiene, stimulus control therapy, sleep restriction therapy, and cognitive restructuring. The document outlines considerations for candidate selection and delivering CBT-I over multiple sessions, including reviewing sleep logs and assessing treatment progress.
Templates Overview With Liver
This document discusses various risks associated with drugs used to treat ADHD. It addresses risks such as sudden death, hypertension, tachycardia, prolonged QT interval, psychiatric issues, seizures, growth effects, sleep problems, tics, liver toxicity, and more. For each risk, it provides information on frequency of association, evidence of causality, impact/severity, moderating factors, differences between drug effects, and considerations around modifying or managing the risks.
Switching DMDs and new pipeline therapies - Dr Eli Silber
Outline:
Where are we now
Therapies
Uncertainties
Induction v.s escalation v.s. rescue
Modelling outcomes
What is progressive disease, SP &PP
Risk reduction
Why is there a need for new therapies?
When is there a need to switch?
Making A New Treatment Decision
Looking at how to know when it is time for new treatment, how to make a decision about new treatment, and how to weigh your options.
PMDD Treatment
PMDD is a severe form of premenstrual disorder that affects 3-8% of women, with debilitating symptoms such as severe mood swings, unbearable pain, and feeling out of control that can damage relationships. However, the document encourages that there is hope to start living fully again by learning more about treatment options at www.PMDDTreatment.org.
Deficits in Emotion-Regulation: Article Review for School
The document summarizes a research article that studied whether emotion regulation skills predict alcohol use during and after treatment for alcohol dependence. The study involved 116 mostly male Caucasian participants who consumed an average of 1,728 grams of alcohol per day and completed an average of 98 days of treatment. Tests found that participants who consumed alcohol during treatment had worse emotion regulation skills compared to those who remained sober, and the same was true three months later. The summary calls for more diverse samples, validated behavior documentation, and randomized controlled trials in future studies.
Medications That Cause Hair Loss - Dr. Alan Bauman
There are many prescription medications that are known to be associated with hair loss. It is important for doctors and patients to be aware of common hair loss risk factors, such as heredity/genetics, as well as other triggers for thinning or shedding hair. Some of the commonly prescribed categories of drugs that can cause hair loss include: antihypertensives (blood pressure), cholesterol / statins, hormone replacement like thyroid, testosterone, etc., mood modulators / anti-depressants, antibiotics, anti-acne, anti-fungals, chemotherapy agents and more. Find out which medications can cause hair loss and what strategy we use to treat the situation.
Dr. Alan J Bauman - Diplomate, American Board of Hair Restoration Surgery
www.baumanmedical.com
Msnc5396 adv pharm application paper powerpoint 2
Midazolam is a short-acting benzodiazepine used for acute anxiety, procedural sedation, anesthesia induction, seizures, and sedation of intubated patients. It works by enhancing the effect of the neurotransmitter GABA at GABA-A receptors in the brain. Midazolam has a rapid onset and short duration, making it suitable for acute care situations where sedation is needed. However, it requires monitoring by skilled clinicians due to potential adverse effects like respiratory depression. Effective interprofessional collaboration is important when using midazolam to optimize patient outcomes and safety.
Chemobrain
Mika Ghosh presented on chemobrain, a condition characterized by cognitive problems experienced by some cancer survivors during and after chemotherapy treatment. Chemobrain symptoms include difficulties with concentration, short-term memory, mental fogginess, and confusion. While the exact causes are unknown, chemotherapy and other cancer treatments, as well as factors like fatigue, stress, and sleep problems may contribute. Symptoms typically improve over time after treatment ends but can last over a year for some patients. Lifestyle changes and medications may help alleviate symptoms but chemobrain cannot currently be prevented.
Neuro cognitive disorders
- Neurocognitive disorders include delirium, disorders due to Lewy bodies, Alzheimer's disease, frontotemporal disorders, vascular disorders, and traumatic brain injuries.
- Delirium involves an acute change in consciousness and cognition that fluctuates in severity. It is often caused by medical issues, medications, or substance withdrawal. Treatment focuses on resolving the underlying cause.
- Disorders like those due to Lewy bodies, Alzheimer's disease, and frontotemporal disorders cause progressive cognitive decline due to brain changes. Symptoms and severity vary by type. Management includes medications, environmental modifications, and supportive care.
- Vascular and traumatic brain injury disorders arise from disruptions to the brain's
More Related Content
What's hot
DMT discussion group - Samantha Colhoun
1) Samantha Colhoun leads discussion groups for MS patients in Birmingham to educate them about disease-modifying therapies (DMTs) due to large waiting lists and clinic capacity issues.
2) The groups have separate sessions for first-line DMTs, Lemtrada, and Fingolimod. Patients are provided information and can handle demonstration devices.
3) During the groups, patients learn about various DMT options including how they work, side effects, monitoring needs, and adherence requirements through a presentation and discussion with a nurse.
Biomarkers in psychiatry
This document discusses the potential for using genetic biomarkers to improve treatment for psychiatric disorders. It notes that while the causes of psychiatric disorders are still unclear, identifying genetic markers that predict treatment response could help tailor medication selection. The document outlines several studies that have identified candidate genes associated with response to antidepressants and other psychotropic drugs. It acknowledges limitations but argues that further research in pharmacogenetics, using larger, more standardized studies, could help incorporate genetic testing into clinical practice to select safer, more effective treatments for individual patients.
Chronic Pain: Dangers and Opportunities
Dr. Barbara Turner's presentation from TPR's Think Health Science: Pain Management presentation, 6/9/16 at UT Health Science Center.
Dementia notes feb 2012
This document summarizes a presentation on the effectiveness and use of cholinesterase inhibitors in dementia. It discusses the three main cholinesterase inhibitors available in Canada - donepezil, rivastigmine, and galantamine - and provides details on their mechanisms of action, dosing, efficacy evidence, and guidelines for use. It also covers topics like optimizing therapy through adherence and expectations counseling, switching or discontinuing treatment, and situations where cholinesterase inhibitors should not be used, such as in mild cognitive impairment. The overall message is that cholinesterase inhibitors provide modest cognitive and functional benefits for mild to moderate Alzheimer's disease but each patient may respond differently based on tolerability and other factors.
Pain and Addiction: Minding the Medicine Cabinet
Slide show from Texas Public Radio and UTHSCSA's Think Health Science: Pain Management program on June 9, 2016.
Ketamine in Treatment Resistant Depression
1. Dr. Elisa Brietzke gave a presentation on intravenous ketamine as an evidence-based approach for treating depression. She discussed ketamine's mechanisms of action, pharmacokinetics, effectiveness for treating unipolar and bipolar depression based on meta-analyses and clinical studies, common side effects and their management, protocols for administration, and comparisons to esketamine.
2. Ketamine has rapid antidepressant effects within 24 hours when administered intravenously, but its effects only last 3-7 days without maintenance treatment. Repeated infusions over several weeks can provide more sustained benefits. Ketamine is generally well-tolerated but can increase blood pressure and heart rate.
3. While ket
Busting The Myths-Relapse Isn’t Treatment Failure
The National Institute on Drug Abuse (NIDA) describes addiction as a chronic, relapsing brain disease characterized by compulsive drug-seeking behavior despite knowing its harmful consequences. Since the chemicals of the drugs change the chemistry of the brain, addiction is commonly considered a “brain disease.” Due to such long-lasting changes, the problem of witnessing a relapse persists even after recovery.
Sequencing of Disease Modifying Treatments in Multiple Sclerosis - Belinda We...
1) There are two broad categories of disease modifying treatments (DMTs) for multiple sclerosis - drugs of moderate efficacy including beta interferons, glatiramer acetate, teriflunomide, and dimethyl fumarate, and drugs of high efficacy including alemtuzumab and natalizumab.
2) The prevailing practice is treatment escalation, starting with a first-line drug and changing treatments based on tolerability, safety, and efficacy. No relapses, disability progression, or MRI activity (NEDA) indicates treatment success.
3) There is no accepted treatment algorithm in the UK. Involving patients in decision making is important as the treatment landscape becomes more complex
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for cancer homeopat...
Homeopathic Doctor Anita Salunke practices in Chembur, Mumbai, India in her homeopathic clinic Mindheal. Find more information about homeopathic treatment at Mindheal. Welcome to safe, sure and effective homeopathic treatment cancer
Pregnancy & Addiction 2011 - Revision 2
This document provides an overview of addiction and pregnancy, including:
- Rates of drug and alcohol use during pregnancy range from 12-24% and pose risks to fetal development.
- Treatment includes medication-assisted therapy with methadone or buprenorphine, which can improve outcomes compared to untreated addiction.
- Babies exposed to opioids in utero may develop neonatal abstinence syndrome requiring supportive care and sometimes pharmacological treatment.
TBI and Holistic Neuropsychology
The document summarizes a presentation on traumatic brain injury (TBI) assessment and rehabilitation. It defines TBI and outlines the continuum of care, including initial assessment, treatment of primary and secondary injuries, and comprehensive rehabilitation involving multiple disciplines. It emphasizes a holistic neuropsychological approach that empowers patients, conveys understanding of deficits and recovery, and helps patients find meaning through collaborative assessment and goal-setting.
MedicalResearch.com: Medical Research Exclusive Interviews April 28 2015
MedicalResearch.com features exclusive interviews with medical researchers from major and specialty medical and health care journals and meetings.
Cognitive Behavorial Therapy for Insomnia k. Jensen f. Remillard
This document summarizes cognitive behavioral therapy for insomnia (CBT-I). It defines insomnia and discusses predisposing, precipitating, and perpetuating factors. It describes CBT-I as the first-line treatment for insomnia, focusing on addressing dysfunctional thoughts and behaviors. Key components of CBT-I include sleep hygiene, stimulus control therapy, sleep restriction therapy, and cognitive restructuring. The document outlines considerations for candidate selection and delivering CBT-I over multiple sessions, including reviewing sleep logs and assessing treatment progress.
Templates Overview With Liver
This document discusses various risks associated with drugs used to treat ADHD. It addresses risks such as sudden death, hypertension, tachycardia, prolonged QT interval, psychiatric issues, seizures, growth effects, sleep problems, tics, liver toxicity, and more. For each risk, it provides information on frequency of association, evidence of causality, impact/severity, moderating factors, differences between drug effects, and considerations around modifying or managing the risks.
Switching DMDs and new pipeline therapies - Dr Eli Silber
Outline:
Where are we now
Therapies
Uncertainties
Induction v.s escalation v.s. rescue
Modelling outcomes
What is progressive disease, SP &PP
Risk reduction
Why is there a need for new therapies?
When is there a need to switch?
Making A New Treatment Decision
Looking at how to know when it is time for new treatment, how to make a decision about new treatment, and how to weigh your options.
PMDD Treatment
PMDD is a severe form of premenstrual disorder that affects 3-8% of women, with debilitating symptoms such as severe mood swings, unbearable pain, and feeling out of control that can damage relationships. However, the document encourages that there is hope to start living fully again by learning more about treatment options at www.PMDDTreatment.org.
Deficits in Emotion-Regulation: Article Review for School
The document summarizes a research article that studied whether emotion regulation skills predict alcohol use during and after treatment for alcohol dependence. The study involved 116 mostly male Caucasian participants who consumed an average of 1,728 grams of alcohol per day and completed an average of 98 days of treatment. Tests found that participants who consumed alcohol during treatment had worse emotion regulation skills compared to those who remained sober, and the same was true three months later. The summary calls for more diverse samples, validated behavior documentation, and randomized controlled trials in future studies.
Medications That Cause Hair Loss - Dr. Alan Bauman
There are many prescription medications that are known to be associated with hair loss. It is important for doctors and patients to be aware of common hair loss risk factors, such as heredity/genetics, as well as other triggers for thinning or shedding hair. Some of the commonly prescribed categories of drugs that can cause hair loss include: antihypertensives (blood pressure), cholesterol / statins, hormone replacement like thyroid, testosterone, etc., mood modulators / anti-depressants, antibiotics, anti-acne, anti-fungals, chemotherapy agents and more. Find out which medications can cause hair loss and what strategy we use to treat the situation.
Dr. Alan J Bauman - Diplomate, American Board of Hair Restoration Surgery
www.baumanmedical.com
Msnc5396 adv pharm application paper powerpoint 2
Midazolam is a short-acting benzodiazepine used for acute anxiety, procedural sedation, anesthesia induction, seizures, and sedation of intubated patients. It works by enhancing the effect of the neurotransmitter GABA at GABA-A receptors in the brain. Midazolam has a rapid onset and short duration, making it suitable for acute care situations where sedation is needed. However, it requires monitoring by skilled clinicians due to potential adverse effects like respiratory depression. Effective interprofessional collaboration is important when using midazolam to optimize patient outcomes and safety.
What's hot (20)
Sequencing of Disease Modifying Treatments in Multiple Sclerosis - Belinda We...
Sequencing of Disease Modifying Treatments in Multiple Sclerosis - Belinda We...
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for cancer homeopat...
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for cancer homeopat...
MedicalResearch.com: Medical Research Exclusive Interviews April 28 2015
MedicalResearch.com: Medical Research Exclusive Interviews April 28 2015
Cognitive Behavorial Therapy for Insomnia k. Jensen f. Remillard
Cognitive Behavorial Therapy for Insomnia k. Jensen f. Remillard
Switching DMDs and new pipeline therapies - Dr Eli Silber
Switching DMDs and new pipeline therapies - Dr Eli Silber
Deficits in Emotion-Regulation: Article Review for School
Deficits in Emotion-Regulation: Article Review for School
Medications That Cause Hair Loss - Dr. Alan Bauman
Medications That Cause Hair Loss - Dr. Alan Bauman
Similar to The Mesothelioma Center's September Support Group Session - Coping with "Chemo Brain"
Chemobrain
Mika Ghosh presented on chemobrain, a condition characterized by cognitive problems experienced by some cancer survivors during and after chemotherapy treatment. Chemobrain symptoms include difficulties with concentration, short-term memory, mental fogginess, and confusion. While the exact causes are unknown, chemotherapy and other cancer treatments, as well as factors like fatigue, stress, and sleep problems may contribute. Symptoms typically improve over time after treatment ends but can last over a year for some patients. Lifestyle changes and medications may help alleviate symptoms but chemobrain cannot currently be prevented.
Neuro cognitive disorders
- Neurocognitive disorders include delirium, disorders due to Lewy bodies, Alzheimer's disease, frontotemporal disorders, vascular disorders, and traumatic brain injuries.
- Delirium involves an acute change in consciousness and cognition that fluctuates in severity. It is often caused by medical issues, medications, or substance withdrawal. Treatment focuses on resolving the underlying cause.
- Disorders like those due to Lewy bodies, Alzheimer's disease, and frontotemporal disorders cause progressive cognitive decline due to brain changes. Symptoms and severity vary by type. Management includes medications, environmental modifications, and supportive care.
- Vascular and traumatic brain injury disorders arise from disruptions to the brain's
neuro-cognitive disorders.pptx
The document discusses several neurocognitive disorders including delirium, neurocognitive disorder due to Lewy bodies, neurocognitive disorder due to Alzheimer's disease, frontotemporal neurocognitive disorder, vascular neurocognitive disorder, and neurocognitive disorder due to traumatic brain injury. It provides details on the causes, symptoms, risk factors, and treatment options for each disorder. The disorders are characterized by impairments in cognitive functioning and mental abilities caused by underlying conditions that damage brain cells or their connections.
How to Manage Chemobrain
Audio and slides for this presentation are available on YouTube: http://youtu.be/49JdPPPRFNw
Cognitive effects of cancer and cancer treatment -- also known as chemobrain -- are widely recognized. Dr. Fremonta Meyer from Dana-Farber Cancer Institute, talks about what chemobrain is, research into its effects, and how to manage and/or treat it.
For more information, watch our YouTube video on chemobrain here:
http://www.youtube.com/watch?v=iK1UqTnD5GI
Alzheimer Disease New.ppt
1) Alzheimer's disease is a progressive brain disorder that destroys memory and thinking skills. The main pathologies are amyloid plaques and neurofibrillary tangles in the brain.
2) Current treatments only temporarily slow the worsening of symptoms but do not stop or reverse the disease process. Cholinesterase inhibitors and memantine are used to manage cognitive and behavioral symptoms.
3) The FDA recently approved aducanumab as the first drug that targets and reduces amyloid plaques in the brain, which may slow clinical decline in Alzheimer's disease.
Depression in Primary Care
Dr Vairam presented on depression in primary care. The presentation covered:
1. Defining depression and its diagnostic criteria.
2. The importance of screening for depression in primary care, as it is often missed or misdiagnosed. Conditions like hypothyroidism, hypercalcemia, anemia, diabetes, fibromyalgia, chronic fatigue syndrome, arthritis, stroke, and heart disease can cause similar symptoms.
3. Special populations like pregnant and postpartum women are also at high risk for depression. Correct diagnosis and treatment in primary care is important to manage depression and reduce negative impacts.
Antidepressants
The document describes various classes of antidepressant drugs, including:
1. Tricyclic antidepressants (TCAs) like amitriptyline
2. Monoamine oxidase inhibitors (MAOIs) like phenelzine that irreversibly inhibit the MAO enzyme
3. Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine that selectively inhibit reuptake of serotonin
It also discusses the biological factors and mechanisms of depression, such as genetic and biochemical influences on neurotransmitter systems in the brain.
2015 Cancer Survivorship Conference - Optimizing Brain Health
1) The document discusses optimizing brain health through regular physical and cognitive exercise, social engagement, primary care, sleep, nutrition, and limiting medication side effects.
2) It describes "chemo-brain" as cognitive difficulties reported by some cancer survivors after chemotherapy and summarizes recent research showing chemo-brain is a real but complex issue, with some studies finding long-term cognitive impacts while others do not.
3) Some factors that may impact chemo-brain risk include individual pre-chemo vulnerabilities, stress, coping style, and expectation biases in self-reported cognitive measures.
Bipolar disorder treatment
There are various treatment methods for bipolar disorder, including; drug therapy, psychotherapy, mental health supplements and ect. http://mentalhealthlivingwithbipolar.blogspot.com/p/blog-page_27.html
Chemotherapy and its side effects Dr Mehr Wali shah
Chemotherapy is the most widely used treatment for pediatric cancer. It involves combinations of drugs that target rapidly dividing cells. Common side effects include fatigue, anemia, inflammation of the mucous membranes, appetite loss, skin and nail changes, cognitive problems, decreased urination, brain fog, anxiety, depression, and temporary hair loss. These side effects can range from mild to debilitating and impact patients physically and emotionally as they undergo cancer treatment. Chemotherapy aims to destroy cancer cells but can also damage healthy cells, especially those in the bone marrow, digestive system, and skin. Managing side effects is an important part of cancer care.
Dementia
This document provides an overview of dementia, including:
- Dementia is a general term for cognitive decline caused by various underlying diseases and disorders. Alzheimer's disease is the most common cause.
- Worldwide prevalence is around 50 million people currently living with dementia. This number is projected to reach 152 million by 2050 due to increased life expectancy.
- Risk factors for dementia include age, family history, head trauma, depression, and certain genetic disorders.
- Symptoms include memory loss, impaired thinking, orientation issues, personality changes, and difficulties with language.
- Dementia is classified based on its underlying cause such as Alzheimer's, vascular, or Lewy body dementia.
-
Therapy methods essay final
Cognitive therapy aims to change negative and unrealistic thoughts that cause depression through supportive counseling and problem solving. However, recent evidence suggests pharmacotherapy may be superior for moderate to severe depression. Electroconvulsive therapy is an intense procedure often used as a last resort for severe depression when patients are suicidal, as it is highly effective but can cause memory issues. Psychopharmacological therapy uses antidepressant drugs, which the NIMH study found were highly effective for severe depression compared to placebo, though they only treat symptoms and not underlying issues like cognitive therapy aims to. Each treatment targets depression differently based on severity and has pros and cons.
Therapy methods essay final
The document compares and contrasts three major treatments for Major Depressive Disorder: cognitive therapy, electroconvulsive therapy, and psychopharmacological therapy. Cognitive therapy aims to change negative and unrealistic thoughts through counseling and problem-solving techniques. Electroconvulsive therapy is often a last resort for severe cases, as it is an intense medical procedure that can cause memory issues. Psychopharmacological therapy uses antidepressant drugs, which the National Institute of Mental Health study found highly effective for severe depression. Each treatment targets depression differently, through changing thought patterns, stimulating the brain, or altering biological functioning.
The Mesothelioma Center December Support Group - Coping with Fear of Recurren...
The Mesothelioma Center December Support Group - Coping with Fear of Recurren...The Mesothelioma Center at Asbestos.com
Mesothelioma patients often experience periods of anxiety and fear of their cancer recurring or progressing during breaks from treatment. It is normal and common to have such worries given the incurable nature of mesothelioma. Developing coping strategies can help lessen this anxiety and improve quality of life, such as learning about treatment and follow-up plans, practicing relaxation techniques, keeping busy with distractions, or speaking to a counselor. Counseling and medication have also proven effective at reducing anxiety for some mesothelioma patients.Reversible dementia and delirium
This document discusses reversible causes of dementia and delirium. It begins by defining major neurocognitive disorder and reversible dementias. Common reversible causes of dementia include central nervous system infections, normal pressure hydrocephalus, nutritional deficiencies, drugs, endocrine disorders, depression, and sleep apnea. Delirium is then discussed, including risk factors, pathophysiology, clinical subtypes, DSM-5 criteria, assessment scales, differential diagnosis, course, prevention, and management. Reversible dementias are estimated to account for 8-40% of dementia cases. Early diagnosis and treatment of the underlying cause can improve cognitive functioning.
Understanding Bipolar Disorder: Biopsychosocial Approaches to Mind Body Health
Explores psychological, medical and primary care treatment and self-care for bipolar disorder from the biological bases of brain function and medication management to the psychological integrated care and treatment plan for health complexity and bipolar treatment needs.
Alzheimer's Disease .pptx
Alzheimer's disease is a progressive neurological disorder that causes memory loss and cognitive decline. It is the most common cause of dementia. The causes of Alzheimer's include abnormal protein accumulation in the brain that form plaques and tangles. Early symptoms include memory loss and difficulty completing tasks, which progress to include mood changes, confusion, and withdrawal. Diagnosis involves assessing medical history, cognitive abilities, neurological functions, and brain imaging. Current treatments cannot stop the disease but aim to manage symptoms through cholinesterase inhibitors, NMDA receptor antagonists, and lifestyle interventions.
Dementia309.
Dementia is a clinical syndrome characterized by difficulties with memory, language, psychological changes, and impairments in daily living activities. Alzheimer's disease is the most common cause of dementia. There are currently 12 million people worldwide living with dementia, and this is projected to increase to 25 million by 2040. Early diagnosis allows for treatment of reversible causes, management of comorbid conditions, and initiation of support and pharmacological therapies. However, early recognition can be difficult due to the gradual onset of symptoms and reluctance to diagnose such a serious condition. A diagnosis involves assessing cognitive function through patient reports, informant histories, and cognitive testing.
Post stroke psychiatric symptoms
This document discusses post-stroke psychiatric disorders. It describes five frontosubcortical circuits that are involved in cognition, behavior and movement. Common post-stroke psychiatric conditions include depression, anxiety, apathy, psychosis and pathological laughing/crying. Lesion location can impact the type of psychiatric disorder, such as left anterior lesions increasing risk of depression. Treatment involves pharmacotherapy, such as antidepressants, and psychotherapy. Screening and ongoing monitoring of symptoms is important after a stroke to identify and manage post-stroke psychiatric complications.
Medical Side of Depression and Mesothelioma
Patients with mesothelioma may develop depression, but there are ways to ease the fear and anxiety with antidepressants, counseling and other therapies.
Similar to The Mesothelioma Center's September Support Group Session - Coping with "Chemo Brain" (20)
2015 Cancer Survivorship Conference - Optimizing Brain Health
2015 Cancer Survivorship Conference - Optimizing Brain Health
Chemotherapy and its side effects Dr Mehr Wali shah
Chemotherapy and its side effects Dr Mehr Wali shah
The Mesothelioma Center December Support Group - Coping with Fear of Recurren...
The Mesothelioma Center December Support Group - Coping with Fear of Recurren...
Understanding Bipolar Disorder: Biopsychosocial Approaches to Mind Body Health
Understanding Bipolar Disorder: Biopsychosocial Approaches to Mind Body Health
More from The Mesothelioma Center at Asbestos.com
Managing Mesothelioma Treatment Side Effects
This document discusses managing side effects of mesothelioma treatments through nutrition. It covers common treatments for mesothelioma like chemotherapy, immunotherapy, radiation, and surgery. Each treatment can cause side effects that impact quality of life. Side effects from chemotherapy include nausea, low blood counts, and neuropathy. Nutrition strategies like eating small, frequent meals can help manage immunotherapy side effects. Radiation side effects include fatigue, and packing portable protein snacks is advised. Surgery side effects involve risks of infection, which nutrition before and after can reduce. Unintended weight loss from treatments can be prevented by meeting calorie and protein needs.
FACT: There is No Asbestos Ban in the US
More than 50 countries, including the United Kingdom, Australia, Canada and all 28 countries of the European Union, have banned the use of asbestos. The United States is not one of them.
Impact of Occupational Asbestos Exposure in the U.S.
Over 75 different occupational groups have exposed workers to asbestos. Repeated asbestos exposure puts workers at risk of numerous cancers and serious pulmonary diseases, including mesothelioma and asbestosis.
Exercise and Mesothelioma Treatment
A cancer diagnosis shouldn't stop patients from exercising (if approved by their oncologist.) In fact, exercise can improve a patient's quality of life. Benefits of increased exercise during cancer treatment include less fatigue, stress and anxiety. Over multiple studies, it was shown there was a link between exercise and decreased cancer recurrence. Learn what types of exercise should be incorporated into a cancer survivor's fitness routine.
Talking to Our Loved Ones About Mesothelioma
Cancer is a topic no one wants to learn how to talk about. Mesothelioma is a new experience that can be challenging to navigate socially. Not only we affected by a cancer diagnosis, but so are our family and friends.
Research shows talking about it helps people adjust to the reality of a situation. By talking about it, our brains begin planning and problem-solving to better cope with the situation. We are better able to get our needs met if we communicate how we are feeling and what we need from our loved ones.
With that being said, it is important to remember that we don’t have to share everything with everyone all the time. It's our choice.
Finding the Clinical Trial That's Right for Me
Clinical trials are changing the face of mesothelioma treatment. While researchers and physicians continue to search for a cure, patients can enroll in clinical trials in order to access the latest medical advances available for treating mesothelioma cancer.
Choosing to join a clinical trial is a very personal decision that patients must consider with their caregivers, family members and medical team. Learn more about the pros and cons of mesothelioma clinical trials and find out how to decide if a clinical trial is the right fit.
Minimizing Anger’s Impact When You Have Mesothelioma
Many people think of anger as a negative emotion, but that's not the case. The reality is that most cancer patients feel anger at times: At diagnosis, when treatment is delayed and even after treatment finishes. Anger can actually be a helpful and motivating emotion if channeled properly.
Anger is a very normal and healthy emotion in life as well as when you or a loved one has mesothelioma. Actively engaging with the feeling and finding healthy ways to express it is key to good anger management.
Life After Mesothelioma Cancer Treatment
A mesothelioma diagnosis can drastically change your life. Your days often become focused on appointments with doctors, chemotherapy sessions and routine testing. When you are no longer undergoing active treatment, it can be hard for you and your loved ones to adjust to this "new normal." Learn how to overcome the challenges of adjusting to life after mesothelioma cancer treatments.
Self-Esteem and Mesothelioma
Self-esteem is the value that we have of ourselves. It also includes how we perceive our value in the world and to others. Being diagnosed with a serious, chronic illness such as mesothelioma may lead to a decrease in self-esteem. Sadly, many people with chronic illnesses or disabilities feel “less than” others who may be healthy or able-bodied.
Our value in life is not tied to how much money we make, how many things we build, how clean our home is or how good our lawn looks. Our value is what we mean to others. Cancer does not change what we mean to others.
Minimizing Relationship Strain After a Mesothelioma Diagnosis
Minimizing Relationship Strain After a Mesothelioma DiagnosisThe Mesothelioma Center at Asbestos.com
People vary in their ability and comfort in having conversations about health, illness and emotions that can accompany a cancer diagnosis. This can lead to communication challenges throughout a mesothelioma battle.
Mesothelioma patients and caregivers may notice that some relationships temporarily changed after a mesothelioma diagnosis. That's normal.
To overcome these changes and challenges, survivors should try to have frequent honest conversations about expectations, thoughts and feelings, so misunderstandings and frustrations don’t lead to more serious relationship problems.Understanding Cancer-Related Fatigue
Many cancer patients experience fatigue at before, during and after treatment. Studies show that 20-90% of cancer patients on active treatment experience symptoms of fatigue, and 20-80% of survivors report fatigue after finishing treatment.
Cancer-related fatigue can be unpredictable because a patient may feel energized one day but fatigued another without any change in activity or rest patterns.
Managing Worries When You Have Mesothelioma
When you or a loved one has mesothelioma, it can seem like there is so much to worry about. That's normal. It is a misconception that all worrying is distressful and unproductive. There are healthy levels of worrying that motivate us to do what we need to be happy, successful and healthy. When worrying becomes overwhelming and feels uncontrollable, then most people experience distress and feel anxious. Obviously, the challenge is to keep our level of worry at a range that motivates us, not give us anxiety.
Overcoming Hopelessness After a Mesothelioma Diagnosis
After being diagnosed with an incurable disease such as mesothelioma cancer, it can be difficult to be hopeful. It's important to understand that with all the recent advancements in mesothelioma treatment, it is realistically hopeful to look forward to surviving longer and with a better quality of life.
Preventing Caregiver Burnout
The document discusses the challenges of caregiver burnout, noting that 60% of caregivers are female and 40% report high stress levels. Caregiver stress can occur when the demands of caregiving outweigh a person's ability to meet those demands, potentially leading to burnout if stress is not managed. The document provides tips for caregivers to minimize stress such as asking for help, prioritizing self-care, exercising, and connecting with other caregivers.
Sharing Your Mesothelioma Story
Every mesothelioma survivor is different, which means each story is unique and provides a distinct insight into life with this type of cancer. There are many benefits to sharing your mesothelioma story, but it is also important to prepare for any reactions that may come from hearing your story.
Benefits of Meditation and Relaxation for Mesothelioma
Cancer patients experience a myriad of emotions before, during and after treatment. Emotional effects therapy, such as meditation, can help patients cope with their cancer in everyday life.
Bad-Weather Workouts for Cancer Patients
This document discusses exercise recommendations and options for cancer patients during bad weather. It provides an overview of the benefits of exercise during and after cancer treatment, including improved sleep, decreased fatigue and treatment side effects, and reduced anxiety and depression. However, certain chemotherapy drugs can make patients sensitive to temperature changes and increase fall risks. As such, the document recommends indoor exercise options when weather is poor, such as using home exercise equipment while watching fitness videos, or exercising at indoor locations like malls, yoga studios and gyms. It emphasizes that staying active is important for cancer patients' emotional and physical well-being.
Managing the Challenges of a Rare Cancer
Living with a terminal disease is never easy, but when it is also a rare disease such as mesothelioma, it can be even more challenging as there are additional obstacles to overcome like finding reliable resources, connecting with a specialist and learning about the latest treatment options.
Popular Asbestos-Containing Products
Photos of asbestos-containing household products, from Kent cigarettes and artificial snow to pure serpentine chrysotile jewelry.
Personality, Attitude and Cancer
Many people wonder whether a cancer patient's attitude or personality type can impact their prognosis. In this SlideShare, Dana Nolan, a Mental Health Counselor, takes a closer look at how personality, attitude and cancer relate for our August 2016 support group session.
More from The Mesothelioma Center at Asbestos.com (20)
Impact of Occupational Asbestos Exposure in the U.S.
Impact of Occupational Asbestos Exposure in the U.S.
Minimizing Anger’s Impact When You Have Mesothelioma
Minimizing Anger’s Impact When You Have Mesothelioma
Minimizing Relationship Strain After a Mesothelioma Diagnosis
Minimizing Relationship Strain After a Mesothelioma Diagnosis
Overcoming Hopelessness After a Mesothelioma Diagnosis
Overcoming Hopelessness After a Mesothelioma Diagnosis
Benefits of Meditation and Relaxation for Mesothelioma
Benefits of Meditation and Relaxation for Mesothelioma
Recently uploaded
Allopurinol (Anti-gout drug).pptx
Allopurinol, a uric acid synthesis inhibitor acts by inhibiting Xanthine oxidase competitively as well as non- competitively, Whereas Oxypurinol is a non-competitive inhibitor of xanthine oxidase.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Nano-gold for Cancer Therapy chemistry investigatory project
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Microbiology & Parasitology Exercises Parts of the Microscope
Exercise 1 of Microbiology and Parasitology which is the parts of the microscope and their uses
Brain specific drug delivery.pptx -Mpharm
BBB and BCF
control the entry of compounds into the brain and
regulate brain homeostasis.
restricts access to brain cells of blood–borne compounds and
facilitates nutrients essential for normal metabolism to reach brain cells
Helminthiasis or Worm infestation in Children for Nursing students
Brief description worm infestation/Helminthiasis for Basic B.Sc Nursing students
Selective α1-Blocker.pptx
Selective alpha1 blockers are Prazosin, Terazosin, Doxazosin, Tamsulosin and Silodosin majorly used to treat BPH, also hypertension, PTSD, Raynaud's phenomenon, CHF
Storyboard on Acne-Innovative Learning-M. pharm. (2nd sem.) Cosmetics
Acne is a common skin condition that occurs when hair follicles become clogged with oil and dead skin cells. It typically manifests as pimples, blackheads, or whiteheads, often on the face, chest, shoulders, or back. Acne can range from mild to severe and may cause emotional distress and scarring in some cases.
**Causes:**
1. **Excess Oil Production:** Hormonal changes during adolescence or certain times in adulthood can increase sebum (oil) production, leading to clogged pores.
2. **Clogged Pores:** When dead skin cells and oil block hair follicles, bacteria (usually Propionibacterium acnes) can thrive, causing inflammation and acne lesions.
3. **Hormonal Factors:** Fluctuations in hormone levels, such as during puberty, menstrual cycles, pregnancy, or certain medical conditions, can contribute to acne.
4. **Genetics:** A family history of acne can increase the likelihood of developing the condition.
**Types of Acne:**
- **Whiteheads:** Closed plugged pores.
- **Blackheads:** Open plugged pores with a dark surface.
- **Papules:** Small red, tender bumps.
- **Pustules:** Pimples with pus at their tips.
- **Nodules:** Large, solid, painful lumps beneath the surface.
- **Cysts:** Painful, pus-filled lumps beneath the surface that can cause scarring.
**Treatment:**
Treatment depends on the severity and type of acne but may include:
- **Topical Treatments:** Such as benzoyl peroxide, salicylic acid, or retinoids to reduce bacteria and unclog pores.
- **Oral Medications:** Antibiotics or oral contraceptives for hormonal acne.
- **Procedures:** Such as chemical peels, extraction of comedones, or light therapy for more severe cases.
**Prevention and Management:**
- **Cleanse:** Regularly wash skin with a gentle cleanser.
- **Moisturize:** Use non-comedogenic moisturizers to keep skin hydrated without clogging pores.
- **Avoid Irritants:** Such as harsh cosmetics or excessive scrubbing.
- **Sun Protection:** Use sunscreen to prevent exacerbation of acne scars and inflammation.
Acne treatment can take time, and consistency in skincare routines and treatments is crucial. Consulting a dermatologist can help tailor a treatment plan that suits individual needs and reduces the risk of scarring or long-term skin damage.
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Breast cancer: Post menopausal endocrine therapy
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Ageing, the Elderly, Gerontology and Public Health
Challenges associated with ageing from a public health perspective
Can Traditional Chinese Medicine Treat Blocked Fallopian Tubes.pptx
There are many traditional Chinese medicine therapies to treat blocked fallopian tubes. And herbal medicine Fuyan Pill is one of the more effective choices.
5 Effective Homeopathic Medicines for Irregular Periods
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
PGx Analysis in VarSeq: A User’s Perspective
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
biomechanics of running. Dr.dhwani.pptx
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
Recently uploaded (20)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
Microbiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the Microscope
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
Storyboard on Acne-Innovative Learning-M. pharm. (2nd sem.) Cosmetics
Storyboard on Acne-Innovative Learning-M. pharm. (2nd sem.) Cosmetics
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
Can Traditional Chinese Medicine Treat Blocked Fallopian Tubes.pptx
Can Traditional Chinese Medicine Treat Blocked Fallopian Tubes.pptx
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
The Mesothelioma Center's September Support Group Session - Coping with "Chemo Brain"
- 1. Coping with Chemobrain Dana Nolan MS, LMHC, NCC Licensed Mental Health Counselor September 11, 2013
- 2. What is Chemobrain? Patients say that during and after chemo that their: • Thinking seems foggy • Memory not as sharp • Can’t make decisions Physicians call these “cognitive deficits related to chemo,” but cancer survivors refer to them as part of “chemobrain!” (800) 615-2270
- 3. Symptoms of Chemobrain Memory loss Trouble paying attention Difficulty “word finding” Problems managing daily activities/solving problems Usually resolves completely or considerably within a year of finishing chemotherapy. (800) 615-2270
- 4. Causes • We are unsure of the exact cause of chemobrain. • Progress in helping patients manage it. Hypotheses about causes: • Anxiety • Depression • Hormonal fluctuations • Sleep problems (800) 615-2270 • Low blood counts • Stress • Medication side effects
- 5. NEUROPSYCHOLOGIST EVALUATION Consulted in chronic cases Comprehensive evaluation Recommendations can include medication, cognitive rehabilitation (800) 615-2270
- 6. Mesothelioma patients struggling with chemobrain can do a number of things to minimize the impact of chemobrain… (800) 615-2270
- 9. ORGANIZE YOUR ENVIRONMENT (800) 615-2270
- 10. REPEAT IMPORTANT INFORMATION (800) 615-2270
- 11. KEEP YOUR BRAIN SHARP (800) 615-2270
- 12. SHARE YOUR STRUGGLE (800) 615-2270
- 13. ASK FOR HELP! (800) 615-2270